AzTrials
AzTrials

Le Fort; INCT06317012

Computer-Aided Design/Manufacturing for Le Fort I Osteotomy and 3D-customized Titanium Plate in Orthognathic Surgery

A study testing Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plate in people with Le Fort; I, run by Hams Hamed Abdelrahman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: In orthognathic surgery, virtual planning is gradually taking over in clinical practice. To start with, virtual surgery planning (VSP) is believed to be less time-consuming and less expensive than conventional surgery planning (CSP). Read more about this study

Who is it for?
Ages 20 to 40 years
Conditions the study is for
Le Fort; I
What is being tested?
Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plate
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteEgypt
Study dates
1 May 2022to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with non-syndromic dentofacial deformity requiring isolated Le Fort I with or without bimaxillary osteotomy.
  • Patients with good oral hygiene.
  • Class II or III malocclusion.
  • Patients who were scheduled to undergo a CT scan as a part of their diagnosis and treatment

Who cannot join

  • Patients with acute infection at the surgery site.
  • Patient with Systemic disorders contraindicating surgery.
  • Smokers.
  • Alcohol or drug abuse is prohibited.
  • patients who suffered from craniofacial syndrome;
  • patients who had previous orthognathic surgery;
  • patients who had previous maxillary or mandibular trauma

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Alexandria Faculty of Dentistry

    Alexandria

Other trials in Egypt

About this study

Official title: Assessment Of Computer-Aided Design/Manufacturing for Le Fort I Osteotomy and 3D-customized Titanium Plate in Orthognathic Surgery (Clinical Trial)

Background: In orthognathic surgery, virtual planning is gradually taking over in clinical practice. To start with, virtual surgery planning (VSP) is believed to be less time-consuming and less expensive than conventional surgery planning (CSP). Moreover, the improved visualization of craniofacial deformities, such as occlusal canting and asymmetries, is a further advantage. Aim: To assess the result of Le Fort I osteotomy using CAD/CAM and 3Dcustomized titanium plate with virtual planning in orthognathic surgery. Materials and Methods: 8 patients with vertical maxillary excess will be included in the study. Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plate will be done for the study group. All patients will be followed clinically and radiographically for one month.

Conditions
Le Fort; I
Being tested
Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plateProcedure or surgery

    Le Fort I osteotomy will be performed with the aid of a surgical guide through the mucosal incision at the maxillary vestibule region, providing adequate surgical exposure.

    The planned position will be obtained using a customized titanium plate for precise maxillary position and fixation as planned virtually on the software.

Study groups in NCT06317012
Study groupRoleWhat they receive
Le Fort I osteotomyExperimentalNot described
Receives: Procedure: Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain

    pain will be scored using visual analogue scale. it ranges from 0 to 10, 0 mean no pain and 10 means severe pain

    Measured: 2nd and 7th days

  2. change in edema

    it was evaluated by its ability to pit. The examiner's fingers will press into the dependent area for 5 seconds, and the pitting will be graded on a scale of +1 to+4.

    Measured: 2nd and 7th days

  3. Change in post operative osteotomy position

    Computed tomography (CT) will be used immediately postoperative to assess surgical position by comparing the clinical results with the virtually planned outcome.

    Measured: Immediate post operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2024
  2. Study start1 May 2022
  3. Primary completion30 May 2023
  4. Study completion30 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06317012
Sponsor's protocol ID
0407-03/2022
Status last verified
Mar 2024
First submitted
12 Mar 2024
Last updated
19 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Le Fort I osteotomy using CAD CAM surgical guide and 3Dcustomized plate in people with Le Fort; I, run by Hams Hamed Abdelrahman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain (time frame: 2nd and 7th days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2024; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in